Market Place
Sourcing Support
Genentech`s Biologics Susvimo Receives Supple Approval in US
05 Sep 2025 //
FDA
Genentech’s Biologic Ocrevus Zunovo Receives Suppl Approval in US
18 Aug 2025 //
FDA
Genentech’s Biologics Tecentriq Receives Suppl Approval in US
18 Aug 2025 //
FDA
Genentech’s Biologics Nutropin AQ Receives Suppl Approval
09 Jul 2025 //
FDA
Genentech`s Biologics Hemlibra Receive Suppl Approval in US
08 Jul 2025 //
FDA
Genentech’s Biologics Perjeta Receives Suppl Approval in US
27 Jun 2025 //
FDA
Genentech`s Biologics Susvimo Receives Suppl Approval in US
21 May 2025 //
FDA
Genentech`s Biologics Piasky Receives Suppl Approval in US
14 May 2025 //
FDA
Genentech`s Biologic Susvimo Receives Suppl Approval in US
04 Feb 2025 //
FDA
Genentech`s Biologic Lunsumio Receives Suppl Approval in US
22 Nov 2024 //
FDA
Genentech`s Itovebi (Inavolisib) Receives Approval in US
10 Oct 2024 //
FDA
Genentech`s Biologic Actemra(Tocilizumab) Receives Suppl Approval in US
19 Sep 2024 //
FDA
Genentech`s Biologic Zunovo (Hyaluronidase) Receives in US
13 Sep 2024 //
FDA
Genentech`s Biologic Ocrevus (Ocrelizumab) Receives Approval in US
13 Sep 2024 //
FDA
Genentech Inc Biologic Ocrelizumab Receives Approval in US
21 Jun 2024 //
FDA
Genentech Inc Biologic Crovalimab-Akkz Receives Approval in US
20 Jun 2024 //
FDA
Genentech`s Trastuzumab; Hyaluronidase-Oysk Receives Suppl Approval in US
18 Jun 2024 //
FDA
Genentech Biologic Trastuzumab Receives Suppl Approval in US
18 Jun 2024 //
FDA
Genentech`s Biologic Xolair (omalizumab) Receives Approval in the U.S.
16 Feb 2024 //
FDA
Genentech`s Biologic Lucentis (ranibizumab) Receives Approval in the U.S.
15 Feb 2024 //
FDA
Genentech`s Biologic Pulmozyme (dornase alfa) Receives Approval in the U.S.
09 Feb 2024 //
FDA
Genentech`s Biologic Ocrevus (ocrelizumab) Receives Approval in the U.S.
19 Jan 2024 //
FDA
Genentech`s Biologic Vabysmo (faricimab) Receives Approval in the U.S.
26 Oct 2023 //
FDA
Genentech`s Biologic Ocrevus (ocrelizumab) Receives Approval in the U.S.
18 Aug 2023 //
FDA
Genentech`s Biologic Columvi (Glofitamab) Receives Approval in the U.S.
15 Jun 2023 //
FDA
Genentech`s Biologic Tnkase ( Tenecteplase) Receives Approval in the U.S.
31 Mar 2023 //
FDA
Genentech`s Biologic Xolair (Omalizumab) Receives Approval in the U.S.
17 Mar 2023 //
FDA
Genentech`s Biologic Vabysmo (Faricimab) Receives Approval in the U.S.
28 Jan 2023 //
FDA
Genentech`s Biologic Lunsumio (Mosunetuzumab) Receives Approval in the U.S.
22 Dec 2022 //
FDA
Genentech` Biologic Actemra (Tocilizumab) Receives Approval in the U.S.
21 Dec 2022 //
FDA
Genentech`s Biologic TECENTRIQ (Atezolizumab) Receives Approval in the U.S.
02 Dec 2022 //
FDA
Genentech`s Biologic AVASTIN(Bevacizumab) Receives Approval in the U.S.
18 Sep 2022 //
FDA
Genentech`s Biologic Enspryng (Satralizumab) Receives Approval in the U.S.
14 Sep 2022 //
FDA
Genentech`s Biologic Activase (Alteplase) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Genentech`s Ocrevus (ocrelizumab) Receives EMA Approval in the U.S.
03 Aug 2022 //
FDA
Genentech`s Gazyva (obinutuzumab) Receives BLA Approval in the U.S.
27 Jul 2022 //
FDA
Genentech`s Gazyva (obinutuzumab) Receives Supplemental Approval in U.S.
12 Jul 2022 //
FDA
Genentech`s Hemlibra emicizumab-kxwh Receives Supplemental Approval in U.S.
06 Jun 2022 //
FDA
Genentech`s Ranibizumab Receives Supplemental Approval in U.S.
18 Apr 2022 //
FDA
Genentech`s Biologic Actemra (Tocilizumab) Receives Approval in the U.S.
28 Feb 2022 //
FDA
Genentech`s Biologic Gazyva (Obinutuzumab) Receives Approval in the U.S.
14 Feb 2022 //
FDA
Genentech`s Biologic Vabysmo (Faricimab-svoa) Receives Approval in U.S.
28 Jan 2022 //
FDA
Genentech`s Biologic Tecentriq (Atezolizumab) Receives Approval in the U.S.
21 Jan 2022 //
FDA
Genentech`s Biologic Rituxan (Rituximab) Receives Approval in the U.S.
17 Dec 2021 //
FDA
Genentech`s Biologic Hemlibra (Emicizumab) Receives Approval in the U.S.
16 Dec 2021 //
FDA
Genentech`s Biologic Rituxan (Rituximab) gets Approval in the U.S.
02 Dec 2021 //
FDA
Genentech`s Actemra (tocilizumab) Receives Supplemental Approval in US
26 Oct 2021 //
FDA
Genentech`s Tecentriq (Atezolizumab) Receives Approval in US
09 Oct 2021 //
FDA
Genentech`s Biologics Emicizumab Receives Approval in the US
02 Sep 2021 //
FDA
Genentech`s Generic Daptomycin Receives Approval in the U.S
30 Jun 2021 //
FDA
Genentech`s Biological Rituximab; Hyaluronidase Receives Approval In US
15 Jun 2021 //
FDA
Genentech`s Enspryng (satralizumab) Receives Supplemental Approval In U.S
06 May 2021 //
FDA
Genentech`s Tecentriq (Atezolizumab) Receives Supplemental Approval In U.S
13 Nov 2020 //
FDA
Genentech Inc`s Biological Atezolizumab Receives Approval In US
30 Sep 2020 //
FDA
Genentech`s Avastin (Bevacizumab) Receives Supplemental Approval In U.S
30 Sep 2020 //
FDA
Genentech`s Biological Ado-Trastuzumab Emtansine Receives Approval In US
27 Sep 2020 //
FDA
Genentech`s Rituximab Receives Supplimental Approval In U.S
01 Sep 2020 //
FDA
Genentech`s Ocrevus (Ocrelizumab) Receives Supplimental Approval In U.S
22 May 2020 //
FDA
